Parenteral Drugs India Limited announced earnings results for the third quarter ended December 31, 2019. For the third quarter, the company announced total revenue was INR 72.490 million compared to INR 101.817 million a year ago. Net loss was INR 261.376 million compared to INR 252.463 million a year ago. Basic loss per share was INR 8.77 compared to INR 8.47 a year ago. For the nine months, total revenue was INR 233.391 million compared to INR 296.732 million a year ago. Net loss was INR 821.380 million compared to INR 759.463 million a year ago. Basic loss per share was INR 27.56 compared to INR 25.48 a year ago.